BEAM
Price
$29.46
Change
+$0.17 (+0.58%)
Updated
Sep 3 closing price
Capitalization
3.04B
66 days until earnings call
Intraday BUY SELL Signals
CVKD
Price
$1.28
Change
-$0.05 (-3.76%)
Updated
Sep 3 closing price
Capitalization
4.57M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs CVKD

BEAM vs CVKD Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 141.11B. VRTX holds the highest valuation in this group at 141.11B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2,599%. CELU experienced the highest price growth at 111%, while VBIO experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 53
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: -10 (-100 ... +100)

Market Cap

The average market capitalization across the group is 1.52B. The market cap for tickers in the group ranges from 4.79M to 3.03B. BEAM holds the highest valuation in this group at 3.03B. The lowest valued company is CVKD at 4.79M.

High and low price notable news

The average weekly price growth across all stocks in the group was -9%. For the same group, the average monthly price growth was -10%, and the average quarterly price growth was -37%. BEAM experienced the highest price growth at -3%, while CVKD experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the group was 1,207%. For the same stocks of the group, the average monthly volume growth was 375% and the average quarterly volume growth was 89,056%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 19
P/E Growth Rating: 100
Price Growth Rating: 67
SMR Rating: 95
Profit Risk Rating: 100
Seasonality Score: -50 (-100 ... +100)
VS
BEAM vs. CVKD commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CVKD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (BEAM: $29.46 vs. CVKD: $1.28)
Brand notoriety: BEAM and CVKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 62% vs. CVKD: 31%
Market capitalization -- BEAM: $3.04B vs. CVKD: $4.57M
BEAM [@Biotechnology] is valued at $3.04B. CVKD’s [@Biotechnology] market capitalization is $4.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCVKD’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CVKD’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while CVKD’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 3 bearish.
  • CVKD’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CVKD.

Price Growth

BEAM (@Biotechnology) experienced а -3.35% price change this week, while CVKD (@Biotechnology) price change was -18.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.14%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +2267.37%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

CVKD is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.04B) has a higher market cap than CVKD($4.57M). BEAM YTD gains are higher at: 6.277 vs. CVKD (-81.121). CVKD has higher annual earnings (EBITDA): -12.05M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. CVKD (2.31M). CVKD has less debt than BEAM: CVKD (0) vs BEAM (251M). BEAM has higher revenues than CVKD: BEAM (164M) vs CVKD (0).
BEAMCVKDBEAM / CVKD
Capitalization3.04B4.57M66,630%
EBITDA-349.25M-12.05M2,899%
Gain YTD6.277-81.121-8%
P/E RatioN/AN/A-
Revenue164M0-
Total Cash1.21B2.31M52,513%
Total Debt251M0-
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCVKD
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
CVKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVRI23.280.49
+2.15%
Enviri Corporation
CWT50.530.39
+0.78%
California Water Service
PR23.74-0.08
-0.34%
Permian Resources Corp
GETY0.23-0.01
-2.38%
Getty Images Holdings
JUNS3.26-0.17
-4.96%
Jupiter Neurosciences Inc